M Russel-Szymczyk, V Valov,
A Savova… - BMC endocrine …, 2019 - Springer
Background This analysis evaluates the cost-effectiveness of insulin degludec (degludec)
versus biosimilar insulin glargine U100 (glargine U100) in patients with type 1 (T1DM) and …